加科思药业集团有限公司（加科思-B，01167）于2026年3月17日公告更新翌日披露报表，显示该公司当日回购144,000股普通股，占回购前已发行股份（不包括库存股份）约0.0183%。每股购回价介乎每股6.92港元至7.02港元，合共付出价格1,004,886港元。
公司回购前已发行股份（不包括库存股份）总数为786,633,780股，库藏股数量为5,121,300股。回购完成后，已发行股份（不包括库存股份）数量降至786,489,780股，库藏股增至5,265,300股，总已发行股本维持在791,755,080股。公司此前于2025年6月10日获得购回授权，可回购最多78,873,528股，截至目前已累计回购2,245,500股，占授权总数约0.2847%。
公司在公告中确认，本次回购已遵守香港联交所证券上市规则等相关法规。公告由公司董事王晓洁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.